Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors [Phase 2]
A Phase 2 trial assessing predictive biomarkers of response to sunitinib in poorly differentiated neuroendocrine tumors; the study was termi…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases [Phase 2]
Phase 2 trial update of Yttrium-90 glass microsphere radioembolization (TheraSphere) for patients with liver metastases, completed with resu…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating bevacizumab with temozolomide in neuroendocrine tumors has completed enrollment. The document does not report trial…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut [Phase 3]
Phase 3 trial evaluating antiproliferative effect of octreotide in patients with metastasized midgut neuroendocrine tumors has completed wit…
-
FDA approval · 2011-02-10FDA Approved: OCTREOTIDE ACETATE — Original Application (Mylan Institutional LLC)
The FDA approved the original ANDA for octreotide acetate from Mylan Institutional LLC. This marks the generic approval for this product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating the combination of bevacizumab, a somatostatin analogue, and metronomic capecitabine in patients with advanced neur…
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Pemetrexed in Patients With Advanced Neuroendocrine Tumors [Phase 2]
This clinical trial update reports the completion of a Phase 2 trial evaluating pemetrexed in patients with advanced neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating 5-fluorouracil in combination with Octreotide Long-Acting Release for neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-21Clinical Trial Update: Treatment With SU11248 in Patients With Neuroendocrine Tumors [Phase 2]
Phase 2 trial of SU11248 (sunitinib) in patients with neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia [Phase 2]
Phase 2 trial of complete cytoreductive surgery with intraperitoneal chemohyperthermia for cancers involving the peritoneum was terminated; …